{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T14:44:27Z","timestamp":1775573067888,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"vor","delay-in-days":1461,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Visceral Surgery"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.jviscsurg.2020.04.013","type":"journal-article","created":{"date-parts":[[2020,4,23]],"date-time":"2020-04-23T06:22:55Z","timestamp":1587622975000},"page":"S25-S31","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"S1","title":["Treatment of primary and metastatic peritoneal tumors in the Covid-19 pandemic. Proposals for prioritization from the RENAPE and BIG-RENAPE groups"],"prefix":"10.1016","volume":"157","author":[{"given":"O.","family":"Glehen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Kepenekian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Bouch\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Gladieff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Honore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Abba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Abboud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Arvieux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Bakrin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-B.","family":"Delhorme","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Dartigues","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Durand-Fontanier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Eveno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Fontaine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Gelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Goere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Guyon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Lefevre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Lo Dico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Marchal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Nadeau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Paquette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Pezet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Pocard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Rousset","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Sgarbura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Taibi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-J.","family":"Tuech","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"You","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Villeneuve","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jviscsurg.2020.04.013_bib0170","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1097\/SLA.0000000000001723","article-title":"A perioperative clinical pathway can dramatically reduce failure-to-rescue rates after cytoreductive surgery for peritoneal carcinomatosis: a retrospective study of 666\u00a0consecutive cytoreductions","volume":"265","author":"Passot","year":"2017","journal-title":"Ann Surg"},{"key":"10.1016\/j.jviscsurg.2020.04.013_bib0175","article-title":"Prehabilitation of patients undergoing cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal malignancy","author":"Cortes-Guiral","year":"2020","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.jviscsurg.2020.04.013_bib0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.dld.2020.03.031","article-title":"COVID-19\u00a0epidemic: proposed alternatives in the management of digestive cancers: a French Intergroup clinical point of view (TNCD)","author":"Di Fiore","year":"2020","journal-title":"Dig Liver Dis"},{"issue":"9","key":"10.1016\/j.jviscsurg.2020.04.013_bib0185","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1002\/bjs.10527","article-title":"Evaluation of the peritoneal carcinomatosis index with CT and MRI","volume":"104","author":"Dohan","year":"2017","journal-title":"Br J Surg"},{"key":"10.1016\/j.jviscsurg.2020.04.013_bib0190","article-title":"Peritoneal MRI in patients undergoing cytoreductive surgery and HIPEC: history, clinical applications, and implementation","author":"Low","year":"2019","journal-title":"Eur J Surg Oncol"},{"issue":"5","key":"10.1016\/j.jviscsurg.2020.04.013_bib0195","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1080\/02656736.2017.1317368","article-title":"Concerning CT features used to select patients for treatment of peritoneal metastases, a pictoral essay","volume":"33","author":"Sugarbaker","year":"2017","journal-title":"Int J Hyperthermia"},{"issue":"Suppl 5","key":"10.1016\/j.jviscsurg.2020.04.013_bib0200","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1245\/s10434-016-5519-2","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis in the elderly: a case-controlled","volume":"23","author":"Alyami","year":"2016","journal-title":"Multicenter Study. Ann Surg Oncol"},{"key":"10.1016\/j.jviscsurg.2020.04.013_bib0205","doi-asserted-by":"crossref","DOI":"10.7326\/M20-1133","article-title":"A war on two fronts: cancer care in the time of COVID-19","author":"Kutikov","year":"2020","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jviscsurg.2020.04.013_bib0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.jviscsurg.2020.03.008","article-title":"Strategy for the practice of digestive and oncological surgery during the Covid-19\u00a0epidemic","author":"Tuech","year":"2020","journal-title":"J Visc Surg"},{"issue":"4","key":"10.1016\/j.jviscsurg.2020.04.013_bib0215","doi-asserted-by":"crossref","first-page":"e181","DOI":"10.1016\/S1470-2045(20)30149-2","article-title":"Risk of COVID-19\u00a0for patients with cancer","volume":"21","author":"Wang","year":"2020","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.jviscsurg.2020.04.013_bib0220","doi-asserted-by":"crossref","first-page":"e180","DOI":"10.1016\/S1470-2045(20)30150-9","article-title":"Risk of COVID-19\u00a0for patients with cancer","volume":"21","author":"Xia","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jviscsurg.2020.04.013_bib0225","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2020.0980","article-title":"SARS-CoV-2\u00a0transmission in patients with cancer at a tertiary care hospital in Wuhan, China","author":"Yu","year":"2020","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.jviscsurg.2020.04.013_bib0230","article-title":"Appendiceal tumours and pseudomyxoma peritonei: Literature review with PSOGI\/EURACAN clinical practice guidelines for diagnosis and treatment","author":"Govaerts","year":"2020","journal-title":"Eur J Surg Oncol"},{"issue":"7","key":"10.1016\/j.jviscsurg.2020.04.013_bib0235","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.ejso.2016.03.017","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in 1000\u00a0patients with perforated appendiceal epithelial tumours","volume":"42","author":"Ansari","year":"2016","journal-title":"Eur J Surg Oncol"},{"issue":"20","key":"10.1016\/j.jviscsurg.2020.04.013_bib0240","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1200\/JCO.2011.39.7166","article-title":"Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"30","author":"Chua","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jviscsurg.2020.04.013_bib0245","article-title":"Peritoneal mesothelioma: PSOGI\/EURACAN clinical practice guidelines for diagnosis, treatment and follow-up","author":"Kusamura","year":"2020","journal-title":"Eur J Surg Oncol"},{"issue":"4","key":"10.1016\/j.jviscsurg.2020.04.013_bib0250","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1245\/s10434-012-2845-x","article-title":"The role of perioperative systemic chemotherapy in diffuse malignant peritoneal mesothelioma patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"20","author":"Deraco","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jviscsurg.2020.04.013_bib0255","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ejca.2016.06.002","article-title":"Diffuse malignant peritoneal mesothelioma: evaluation of systemic chemotherapy with comprehensive treatment through the RENAPE Database: multi-Institutional Retrospective study","volume":"65","author":"Kepenekian","year":"2016","journal-title":"Eur J Cancer"},{"issue":"12","key":"10.1016\/j.jviscsurg.2020.04.013_bib0260","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1245\/s10434-017-6033-x","article-title":"Conversion to complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma after bidirectional chemotherapy","volume":"24","author":"Le Roy","year":"2017","journal-title":"Ann Surg Oncol"},{"issue":"18_suppl","key":"10.1016\/j.jviscsurg.2020.04.013_bib0265","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2018.36.18_suppl.LBA3503","article-title":"A UNICANCER phase III trial of hyperthermic intra-peritoneal chemotherapy (HIPEC) for colorectal peritoneal carcinomatosis (PC): PRODIGE 7","volume":"36","author":"Quenet","year":"2018","journal-title":"Journal of Clinical Oncology"},{"issue":"1","key":"10.1016\/j.jviscsurg.2020.04.013_bib0270","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/SLA.0b013e318255486a","article-title":"Progression following neoadjuvant systemic chemotherapy may not be a contraindication to a curative approach for colorectal carcinomatosis","volume":"256","author":"Passot","year":"2012","journal-title":"Ann Surg"},{"issue":"12","key":"10.1016\/j.jviscsurg.2020.04.013_bib0275","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/S1470-2045(16)30500-9","article-title":"Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the analysis and research in cancers of the digestive system (ARCAD) database","volume":"17","author":"Franko","year":"2016","journal-title":"Lancet Oncol"},{"issue":"5","key":"10.1016\/j.jviscsurg.2020.04.013_bib0280","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1200\/JCO.2008.19.7160","article-title":"Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin","volume":"27","author":"Elias","year":"2009","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/j.jviscsurg.2020.04.013_bib0285","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1245\/s10434-014-3647-0","article-title":"Pathological response to neoadjuvant chemotherapy: a new prognosis tool for the curative management of peritoneal colorectal carcinomatosis","volume":"21","author":"Passot","year":"2014","journal-title":"Ann Surg Oncol"},{"issue":"23","key":"10.1016\/j.jviscsurg.2020.04.013_bib0290","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1200\/JCO.18.01688","article-title":"Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for gastric cancer with peritoneal metastases (CYTO-CHIP study): a propensity score analysis","volume":"37","author":"Bonnot","year":"2019","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.jviscsurg.2020.04.013_bib0295","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1245\/s10434-015-5081-3","article-title":"Patients with peritoneal carcinomatosis from gastric cancer treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: is cure a possibility?","volume":"23","author":"Chia","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jviscsurg.2020.04.013_bib0300","series-title":"Conduites \u00e0 tenir initiales devant des patientes atteintes d\u2019un cancer \u00e9pith\u00e9lial de l\u2019ovaire\/Synth\u00e8se","year":"2019"},{"issue":"10","key":"10.1016\/j.jviscsurg.2020.04.013_bib0305","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1056\/NEJMoa0908806","article-title":"Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer","volume":"363","author":"Vergote","year":"2010","journal-title":"N Engl J Med"},{"issue":"14","key":"10.1016\/j.jviscsurg.2020.04.013_bib0310","first-page":"1363","article-title":"Hyperthermic intraperitoneal chemotherapy in ovarian cancer","volume":"378","author":"van Driel","year":"2018","journal-title":"N Engl J Med"},{"issue":"20","key":"10.1016\/j.jviscsurg.2020.04.013_bib0315","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1056\/NEJMoa1902626","article-title":"Secondary surgical cytoreduction for recurrent ovarian cancer","volume":"381","author":"Coleman","year":"2019","journal-title":"N Engl J Med"},{"issue":"15_suppl","key":"10.1016\/j.jviscsurg.2020.04.013_bib0320","doi-asserted-by":"crossref","first-page":"5501","DOI":"10.1200\/JCO.2017.35.15_suppl.5501","article-title":"Randomized controlled phase III study evaluating the impact of secondary cytoreductive surgery in recurrent ovarian cancer: AGO DESKTOP III\/ENGOT ov20","volume":"35","author":"Bois","year":"2017","journal-title":"Journal of Clinical Oncology"},{"issue":"12","key":"10.1016\/j.jviscsurg.2020.04.013_bib0325","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/j.ejso.2013.09.030","article-title":"Peritoneal carcinomatosis treated with cytoreductive surgery and Hyperthermic Intraperitoneal chemotherapy (HIPEC) for advanced ovarian carcinoma: a French multicentre retrospective cohort study of 566\u00a0patients","volume":"39","author":"Bakrin","year":"2013","journal-title":"Eur J Surg Oncol"},{"issue":"5","key":"10.1016\/j.jviscsurg.2020.04.013_bib0330","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1080\/02656736.2017.1301576","article-title":"Complete cytoreductive surgery plus HIPEC for peritoneal metastases from unusual cancer sites of origin: results from a worldwide analysis issue of the Peritoneal Surface Oncology Group International (PSOGI)","volume":"33","author":"Goere","year":"2017","journal-title":"Int J Hyperthermia"}],"container-title":["Journal of Visceral Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878788620301181?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878788620301181?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T07:33:10Z","timestamp":1761809590000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878788620301181"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S1878788620301181"],"URL":"https:\/\/doi.org\/10.1016\/j.jviscsurg.2020.04.013","relation":{},"ISSN":["1878-7886"],"issn-type":[{"value":"1878-7886","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of primary and metastatic peritoneal tumors in the Covid-19 pandemic. Proposals for prioritization from the RENAPE and BIG-RENAPE groups","name":"articletitle","label":"Article Title"},{"value":"Journal of Visceral Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jviscsurg.2020.04.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}